[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

High Blood Pressure Drugs (Hypertension) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

December 2020 | 93 pages | ID: HAB0D2723510EN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global High Blood Pressure Drugs (Hypertension) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global High Blood Pressure Drugs (Hypertension) market segmented into
  • ACEI
  • CCB
  • ARB
Based on the end-use, the global High Blood Pressure Drugs (Hypertension) market classified into
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Based on geography, the global High Blood Pressure Drugs (Hypertension) market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Eli Lilly
  • Pfizer
  • Bayer
  • Symplmed
  • Novartis
  • Merck
  • Sanofi
  • Boryung
  • Reata Pharmaceuticals
  • Lung Biotechnology
  • Yuhan
  • Takeda
  • Alvogen
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL HIGH BLOOD PRESSURE DRUGS (HYPERTENSION) INDUSTRY

2.1 Summary about High Blood Pressure Drugs (Hypertension) Industry
2.2 High Blood Pressure Drugs (Hypertension) Market Trends
  2.2.1 High Blood Pressure Drugs (Hypertension) Production & Consumption Trends
  2.2.2 High Blood Pressure Drugs (Hypertension) Demand Structure Trends
2.3 High Blood Pressure Drugs (Hypertension) Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 ACEI
  4.2.2 CCB
  4.2.3 ARB
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Hospital Pharmacy
  4.3.2 Retail Pharmacy
  4.3.3 Online Pharmacy

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 ACEI
  5.2.2 CCB
  5.2.3 ARB
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Hospital Pharmacy
  5.3.2 Retail Pharmacy
  5.3.3 Online Pharmacy
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 ACEI
  6.2.2 CCB
  6.2.3 ARB
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Hospital Pharmacy
  6.3.2 Retail Pharmacy
  6.3.3 Online Pharmacy
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 ACEI
  7.2.2 CCB
  7.2.3 ARB
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Hospital Pharmacy
  7.3.2 Retail Pharmacy
  7.3.3 Online Pharmacy
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 ACEI
  8.2.2 CCB
  8.2.3 ARB
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Hospital Pharmacy
  8.3.2 Retail Pharmacy
  8.3.3 Online Pharmacy
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 ACEI
  9.2.2 CCB
  9.2.3 ARB
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Hospital Pharmacy
  9.3.2 Retail Pharmacy
  9.3.3 Online Pharmacy
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Eli Lilly
  10.1.2 Pfizer
  10.1.3 Bayer
  10.1.4 Symplmed
  10.1.5 Novartis
  10.1.6 Merck
  10.1.7 Sanofi
  10.1.8 Boryung
  10.1.9 Reata Pharmaceuticals
  10.1.10 Lung Biotechnology
  10.1.11 Yuhan
  10.1.12 Takeda
  10.1.13 Alvogen
10.2 High Blood Pressure Drugs (Hypertension) Sales Date of Major Players (2017-2020e)
  10.2.1 Eli Lilly
  10.2.2 Pfizer
  10.2.3 Bayer
  10.2.4 Symplmed
  10.2.5 Novartis
  10.2.6 Merck
  10.2.7 Sanofi
  10.2.8 Boryung
  10.2.9 Reata Pharmaceuticals
  10.2.10 Lung Biotechnology
  10.2.11 Yuhan
  10.2.12 Takeda
  10.2.13 Alvogen
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table High Blood Pressure Drugs (Hypertension) Product Type Overview
Table High Blood Pressure Drugs (Hypertension) Product Type Market Share List
Table High Blood Pressure Drugs (Hypertension) Product Type of Major Players
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Pfizer
Table Brief Introduction of Bayer
Table Brief Introduction of Symplmed
Table Brief Introduction of Novartis
Table Brief Introduction of Merck
Table Brief Introduction of Sanofi
Table Brief Introduction of Boryung
Table Brief Introduction of Reata Pharmaceuticals
Table Brief Introduction of Lung Biotechnology
Table Brief Introduction of Yuhan
Table Brief Introduction of Takeda
Table Brief Introduction of Alvogen
Table Products & Services of Eli Lilly
Table Products & Services of Pfizer
Table Products & Services of Bayer
Table Products & Services of Symplmed
Table Products & Services of Novartis
Table Products & Services of Merck
Table Products & Services of Sanofi
Table Products & Services of Boryung
Table Products & Services of Reata Pharmaceuticals
Table Products & Services of Lung Biotechnology
Table Products & Services of Yuhan
Table Products & Services of Takeda
Table Products & Services of Alvogen
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global High Blood Pressure Drugs (Hypertension) Market Forecast (Million USD) by Region 2021f-2026f
Table Global High Blood Pressure Drugs (Hypertension) Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global High Blood Pressure Drugs (Hypertension) Market Forecast (Million USD) by Demand 2021f-2026f
Table Global High Blood Pressure Drugs (Hypertension) Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global High Blood Pressure Drugs (Hypertension) Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global High Blood Pressure Drugs (Hypertension) Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global High Blood Pressure Drugs (Hypertension) Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global High Blood Pressure Drugs (Hypertension) Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global High Blood Pressure Drugs (Hypertension) Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global High Blood Pressure Drugs (Hypertension) Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global High Blood Pressure Drugs (Hypertension) Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ACEI Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CCB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ARB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ACEI Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CCB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ARB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ACEI Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CCB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ARB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ACEI Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CCB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ARB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ACEI Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CCB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ARB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ACEI Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure CCB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure ARB Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Bayer 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Symplmed 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Novartis 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Merck 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Boryung 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Reata Pharmaceuticals 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Lung Biotechnology 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Yuhan 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Takeda 2017-2020e
Figure High Blood Pressure Drugs (Hypertension) Sales Revenue (Million USD) of Alvogen 2017-2020e


More Publications